MPEP § 2413 — Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File (Annotated Rules)
§2413 Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File
This page consolidates and annotates all enforceable requirements under MPEP § 2413, including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File
This section addresses Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File.
Key Rules
Sequence Listing Format
In order to ensure consistency and uniformity of a “Sequence Listing XML,” 37 CFR 1.833 defines the content of the “Sequence Listing XML.” 37 CFR 1.834 details the specifics on the technical form and format of the.xml file containing the “Sequence Listing XML” XML file.
In order to ensure consistency and uniformity of a “Sequence Listing XML,” 37 CFR 1.833 defines the content of the “Sequence Listing XML.” 37 CFR 1.834 details the specifics on the technical form and format of the.xml file containing the “Sequence Listing XML” XML file.
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
| Sequence Listing Format | 37 CFR § 1.833 |
| Sequence Listing Format | 37 CFR § 1.834 |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2413 — Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File
Source: USPTO2413 Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
In order to ensure consistency and uniformity of a “Sequence Listing XML,” 37 CFR 1.833 defines the content of the “Sequence Listing XML.” 37 CFR 1.834 details the specifics on the technical form and format of the .xml file containing the “Sequence Listing XML” XML file.